- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, December 13, 2019
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article in Kentucky Today titled “Lower Health Care Costs Act comes with own price” referenced a study published in the August 2019 issue of The American Journal of Managed Care® (AJMC®) titled “Influence of Out-of-Network Payment Standards on Insurer—Provider Bargaining: California’s Experience.”
An Ohio State News article, “Out-of-network costs soar for non-emergency hospitalizations,” highlighted a study published in the December 2019 issue of AJMC® titled “Cost-Sharing Payments for Out-of-Network Care in Commercially Insured Adults.” The study evaluated claims among adults covered by employer-sponsored plans, and it revealed substantial variations in out-of-network cost-sharing payments, which are growing in occurrence. Findings were additionally highlighted in an article by radio.wosu.org, the website of WOSU public radio.
A piece by Next Avenue cited a study published in the September 2018 issue of AJMC® titled “High-Touch Care Leads to Better Outcomes and Lower Costs in a Senior Population.” The study analyzed the impact of a high-touch primary care model among a Medicare Advantage population in comparison with a standard practice—based model.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
